查看购物车
  • Traditional Chinese
  • English
  • Japanese
  • Korean
全球渠道止血市场-2022-2029
市场调查报告书
商品编码
1129262

全球渠道止血市场-2022-2029

Global Channel Coagulometer Market - 2022-2029
出版日期: | 出版商: DataM Intelligence | 英文 160 Pages | 商品交期: 约2个工作天内

价格

※ 本网页内容可能与最新版本有所差异。详细情况请与我们联繫。

简介目录

市场动态

渠道止血的创新有望推动市场增长。

由 Medsource Ozone Biomedicals 创建的现代 4 通道光凝分析仪具有触摸屏界面，用户舒适，并采用最新的血栓检测技术。

此外，2021 年 10 月 20 日，在凝血领域推出了一种革命性的新产品，以提高临床表现和生产力。 Diagon Ltd. 的凝血分析仪产品的首次亮相是由着名的医疗设备供应商 Trivitron Healthcare 宣布的。签署合作协议后，Trivitron 宣布与 Diagon-Vanguard Diagnostics India 合作为印度诊断市场推出这些产品。此次发布对医学界来说是个好兆头，因为它扩大了患者管理并提高了临床决策的有效性。匈牙利对角线生产的COAG线自动和半自动POC系统是新产品之一。它们用于评估抗凝剂和止血治疗的功效，并降低各种手术过程中的出血风险。因此，从上述陈述来看，预计市场将在预测期内受到驱动。

约束

分析仪的高成本、严格的监管审批以及缺乏管理分析仪的熟练专业人员可能是在预测期内阻碍市场的因素。

行业分析

渠道止血市场根据供应链、定价分析和监管分析等各种行业因素对市场进行深入分析。

COVID-19 影响分析

COVID-19 大流行对市场产生了适度的影响。了解大流行期间与 COVID-19 凝血病相关的出血和血栓事件的频率以及凝血病检测在确定出血或血栓形成的可能性和疾病严重程度的临床价值是极其重要的。除 D-二聚体外，凝血□原时间 (PT) 的延长也与生存率下降和危重患者管理的需要有关。弥散性血管内凝血 (DIC) 与超过 70% 的患者因感染死亡有关，并且已根据实验室结果进行了描述。因此，渠道聚合器的需求量越来越大。同时，COVID-19 削弱了供应链，并造成全球渠道聚合器产品短缺。因此，COVID-19 大流行正在影响市场。但是，预计这种情况将在预测期内逐渐改善。

全球渠道止血市场报告将提供对大约 45 多个市场数据表、40 多个数字和 160 页的访问。

内容

第一章研究方法与范围

  • 调查方法
  • 调查目的和范围

第 2 章市场定义和概述

第 3 章执行摘要

第 4 章市场动态

  • 市场影响因素
    • 驱动程序
      • 渠道聚合器的创新有望推动市场增长。
    • 限制因素
      • 分析设备的高成本预计将在预测期内受到阻碍。
    • 机会
    • 影响分析

第五章行业分析

  • 波特的五种力量
  • 未满足的需求
  • 供应链
  • 定价分析

第 6 章 COVID-19 分析

  • COVID-19 的市场分析
    • COVID-19 发布前的市场情景
    • COVID-19 的当前市场情景
    • COVID-19 后或未来情景
  • COVID-19 期间的价格动态
  • 供需范围
  • 大流行期间与市场相关的政府举措
  • 製造商的战略举措
  • 总结

第 7 章按产品类型

  • 2 通道血凝仪
  • 4 通道血凝仪
  • 6 通道血凝仪
  • 7 通道血凝仪
  • 8 通道血凝仪

第 8 章按模态类型

  • 独立的血凝仪
  • 台式血凝测量仪
  • 手持式/便携式血凝仪
  • 其他

第 9 章，最终用户

  • 医院
  • 学术和研究机构
  • 委託研究机构
  • 诊断机构
  • 其他

第 10 章按地区划分

  • 北美
    • 美国
    • 加拿大
    • 墨西哥
  • 欧洲
    • 德国
    • 英国
    • 法国
    • 意大利
    • 西班牙
    • 其他欧洲
  • 南美洲
    • 巴西
    • 阿根廷
    • 其他南美洲
  • 亚太地区
    • 中国
    • 印度
    • 日本
    • 澳大利亚
    • 其他亚太地区
  • 中东和非洲

第 11 章竞争格局

  • 主要发展和战略
  • 公司份额分析
  • 产品基准
  • 值得关注的重点公司列表

第 12 章公司简介

  • HORIBA Medical
    • 公司概况
    • 产品组合和描述
    • 主要亮点
    • 财务摘要
  • LINEAR CHEMICALS S.L.U.
  • BioSystems S.A.
  • Rayto Life and Analytical Sciences Co.,Ltd.
  • Micro Lab Instruments
  • TECO Medical Instruments
  • Helena Biosciences
  • Genrui Biotech Inc.
  • Biobase
  • Maccura Biotechnology Co., Ltd.

第 13 章全球渠道止血市场 - DataM

简介目录
Product Code: DMCD5847

Market Overview

Channel Coagulometer Market size was valued US$ YY million in 2021 and is estimated to reach US$ YY million by 2029, growing at a CAGR of YY % during the forecast period (2022-2029).

A blood coagulometer is an analyzer used to test the coagulation efficiency of blood to diagnose and assess bleeding disorders such as hemophilia or monitor patients taking anticoagulant medicines such as aspirin, heparin, or warfarin. There are six to seven different kinds, including the two-channel coagulometer, four-channel coagulometer, six-channel coagulometer, seven-channel coagulometer, and eight-channel coagulometer, and so on. Moreover, it also assists doctors in developing individualized antiplatelet therapy.

Market Dynamics

Innovations in the channel coagulometer are expected to drive market growth.

A modern four-channel photo-optical coagulation analyzer created by Medsource Ozone Biomedicals features a touch screen interface for user comfort latest clot detection technology. Three reagent stations and 22 sample positions for incubation, automatic optical start, LED technology Results in INR, Ratio, Quick%, Low reagent and sample volume required, no bars or stirrers needed, an instrument that requires no upkeep Can perform four tests at once (simultaneously), Compatibility with PT, aPTT, TT, FIB, D-Dimer, Factors, Protein C, Protein S, and essentially any Hemostasis assay, etc. Observations from 180 patients.

Moreover, an innovative new product was launched in the Coagulation segment on October 20, 2021, to improve clinical outcomes and productivity. The debut of a new line of Coagulation Analyzer products made by Diagon Ltd. has been announced by Trivitron Healthcare, a prominent provider of medical devices. After signing a collaboration agreement, Trivitron announced the launch of these products for the Indian diagnostics market in collaboration with Diagon-Vanguard Diagnostics India. This launch bodes well for the medical community because it expands patient management and improves clinical decision-making effectiveness. The COAG Line automated, semi-automated, and POC systems produced by Diagon Hungary are among the new products. They are used to assess the effectiveness of anticoagulant medications and hemostatic therapy and to reduce the risk of bleeding during extensive procedures. Thus, from the above statements, the market is expected to drive in the forecast period.

Restraint:

The high cost of the analyzers, stringent regulatory approvals, and lack of skilled professionals for managing the analyzers are the factors the market is expected to get hampered in the forecast period.

Industry Analysis

The channel coagulometer market provides in-depth analysis of the market based on various industry factors such as supply chain, pricing analysis, regulatory analysis etc.

COVID-19 Impact Analysis

The COVID-19 pandemic has moderately impacted the market. During the pandemic, it is crucial to comprehend the frequency of bleeding and thrombotic symptoms linked to COVID-19 coagulopathy, as well as the clinical value of abnormal coagulation testing to identify the likelihood of bleeding, thrombosis, and the severity of the sickness. Besides D-dimer, a prolonged prothrombin time (PT) has also been linked to a lower chance of survival and a greater demand for critical care. Disseminated intravascular coagulation (DIC), linked to >70% of patients who die from the infection, has been described based on test results. As a result, the channel coagulometer is now more in demand. In contrast, COVID-19 has weakened the supply chain and created a global shortage of channel coagulometer products. Thus, the COVID-19 pandemic has affected the market. However, the situation is expected to improve gradually in the forecast period.

Segment Analysis

Hospital segment is expected to hold the largest market share in channel coagulometer market.

The hospital segment accounted for the largest market share in 2021. The increasing number of hospitals and their growing infrastructure are the factors to drive the market growth. For instance, in 2020, Colombia had the highest hospital count, around 10,899. In comparison, Japan had around 8,238 hospitals. Moreover, as of November 18, 2021, 80,136 Ayushman Bharat-Health and Wellness Centres (AB-HWCs) are operational in India. As of November 18, 2021, 638 e-Hospitals are established across India as part of the central government's 'Digital India' initiative. Therefore, it has led to increasing demand for channel coagulometers. Thus, from the above statements, the market segment accounted for the largest market share in the forecast period.

Geographical Analysis

North America region holds the largest market share in the global channel coagulometer market

In 2021, the North American channel coagulometer accounted for the highest revenue share in the global market. The increasing prevalence of blood clotting-related disorders, technological advancement in the channel coagulometer, well-established infrastructure, and product launches by the key market players are the factors that drive the market in the forecast period. For instance, Von Willebrand disease, the most prevalent genetic bleeding disorder in America brought on by clotting proteins, affects a lot more people. Both sexes are susceptible to Von Willebrand disease. Moreover, the most common inherited bleeding disorder among American women is a common cause of heavy menstrual bleeding and other bleeding problems in women and adolescent girls. Therefore, it has increased the demand for channel coagulometers in the region; thus, the North American region has the largest market share.

Competitive Landscape

Major key players in the channel coagulometer market are HORIBA Medical, LINEAR CHEMICALS S.L.U., BioSystems S.A., Rayto Life and Analytical Sciences Co.,Ltd., Micro Lab Instruments, TECO Medical Instruments, Helena Biosciences, Genrui Biotech Inc., Biobase and Maccura Biotechnology Co., Ltd.

Micro Lab Instruments:

Overview:

Micro Lab Instruments is one of India's fastest-growing diagnostic companies based in Ahmedabad, the Western state of India, established in 1993. The company manufacturers and exporters a wide range of Biochemistry Analyzer, Electrolyte Analyzer, Elisa Reader, Dry Bath Incubator, Elisa Plate Washer, Single Channel coagulometers and much more. The organization is supported by a team of experienced professionals, which directs its sincere and painstaking efforts to provide its customers with the best solution for their needs. Moreover, the company exports its products to countries including Egypt, Peru, Ethiopia, South Africa and Kenya.

Product Portfolio:

Single Channel Coagulometer:

Main Features:

  • Semi-automatic Single channel coagulometer
  • Printout of the graph and results
  • On-board storage capability up to 20 assays
  • Open system with user friendly software
  • All methods creatable, editable, copy and delete
  • Automated calculation results in seconds, %, INR, g/l, mg/dl, Ratio
  • Calibration/reference curves editable up to 9 measurement points
  • Automatic start-pipette connectable
  • Automated cuvette detection and calculation
  • Data transmission to SD-card or external PC (Optional)

The global channel coagulometer market report would provide an access to an approx. 45+market data table, 40+figures and 160pages.

Table of Contents

1. Methodology and Scope

  • 1.1. Research Methodology
  • 1.2. Research Objective and Scope of the Report

2. Market Definition and Overview

3. Executive Summary

4. Market Dynamics

  • 4.1. Market Impacting Factors
    • 4.1.1. Drivers
      • 4.1.1.1. Innovations in the channel coagulometer are expected to drive market growth.
    • 4.1.2. Restraints:
      • 4.1.2.1. The high cost of the analyzers is expected to get hampered in the forecast period.
    • 4.1.3. Opportunity
    • 4.1.4. Impact Analysis

5. Industry Analysis

  • 5.1. Porter's Five Forces
  • 5.2. Unmet Needs
  • 5.3. Supply Chain
  • 5.4. Pricing Analysis

6. COVID-19 Analysis

  • 6.1. Analysis of Covid-19 on the Market
    • 6.1.1. Before COVID-19 Market Scenario
    • 6.1.2. Present COVID-19 Market Scenario
    • 6.1.3. After COVID-19 or Future Scenario
  • 6.2. Pricing Dynamics Amid Covid-19
  • 6.3. Demand-Supply Spectrum
  • 6.4. Government Initiatives Related to the Market During Pandemic
  • 6.5. Manufacturers Strategic Initiatives
  • 6.6. Conclusion

7. By Product Type

  • 7.1. Introduction
    • 7.1.1. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Product Type
    • 7.1.2. Market Attractiveness Index, By Product Type Segment
  • 7.2. 2 Channel Coagulometer*
    • 7.2.1. Introduction
    • 7.2.2. Market Size Analysis, US$ Million, 2020-2029 and Y-o-Y Growth Analysis (%), 2021-2029
  • 7.3. 4 Channel Coagulometer
  • 7.4. 6 Channel Coagulometer
  • 7.5. 7 Channel Coagulometer
  • 7.6. 8 Channel Coagulometer

8. By Modality Type

  • 8.1. Introduction
    • 8.1.1. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Modality Type
    • 8.1.2. Market Attractiveness Index, By Modality Type Segment
  • 8.2. Stand-Alone Coagulometer*
    • 8.2.1. Introduction
    • 8.2.2. Market Size Analysis, US$ Million, 2020-2029 and Y-o-Y Growth Analysis (%), 2021-2029
  • 8.3. Bench-Top Coagulometer
  • 8.4. Handhled/Protable Coagulometer
  • 8.5. Others

9. By End user

  • 9.1. Introduction
    • 9.1.1. Market Size Analysis, and Y-o-Y Growth Analysis (%), By End user
    • 9.1.2. Market Attractiveness Index, By End user Segment
  • 9.2. Hospitals*
    • 9.2.1. Introduction
    • 9.2.2. Market Size Analysis, US$ Million, 2020-2029 and Y-o-Y Growth Analysis (%), 2021-2029
  • 9.3. Academic & Research Institutions
  • 9.4. Contract Research Organization
  • 9.5. Diagnostic Laboratories
  • 9.6. Others

10. By Region

  • 10.1. Introduction
    • 10.1.1. Market Size Analysis, US$ Million, 2020-2029 and Y-o-Y Growth Analysis (%), 2021-2029, By Region
    • 10.1.2. Market Attractiveness Index, By Region
  • 10.2. North America
    • 10.2.1. Introduction
    • 10.2.2. Key Region-Specific Dynamics
    • 10.2.3. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Product Type
    • 10.2.4. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Modality Type
    • 10.2.5. Market Size Analysis, and Y-o-Y Growth Analysis (%), By End user
    • 10.2.6. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Country
      • 10.2.6.1. U.S.
      • 10.2.6.2. Canada
      • 10.2.6.3. Mexico
  • 10.3. Europe
    • 10.3.1. Introduction
    • 10.3.2. Key Region-Specific Dynamics
    • 10.3.3. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Product Type
    • 10.3.4. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Modality Type
    • 10.3.5. Market Size Analysis, and Y-o-Y Growth Analysis (%), By End user
    • 10.3.6. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Country
      • 10.3.6.1. Germany
      • 10.3.6.2. U.K.
      • 10.3.6.3. France
      • 10.3.6.4. Italy
      • 10.3.6.5. Spain
      • 10.3.6.6. Rest of Europe
  • 10.4. South America
    • 10.4.1. Introduction
    • 10.4.2. Key Region-Specific Dynamics
    • 10.4.3. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Product Type
    • 10.4.4. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Modality Type
    • 10.4.5. Market Size Analysis, and Y-o-Y Growth Analysis (%), By End user
    • 10.4.6. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Country
      • 10.4.6.1. Brazil
      • 10.4.6.2. Argentina
      • 10.4.6.3. Rest of South America
  • 10.5. Asia Pacific
    • 10.5.1. Introduction
    • 10.5.2. Key Region-Specific Dynamics
    • 10.5.3. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Product Type
    • 10.5.4. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Modality Type
    • 10.5.5. Market Size Analysis, and Y-o-Y Growth Analysis (%), By End user
    • 10.5.6. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Country
      • 10.5.6.1. China
      • 10.5.6.2. India
      • 10.5.6.3. Japan
      • 10.5.6.4. Australia
      • 10.5.6.5. Rest of Asia Pacific
  • 10.6. Middle East and Africa
    • 10.6.1. Introduction
    • 10.6.2. Key Region-Specific Dynamics
    • 10.6.3. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Product Type
    • 10.6.4. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Modality Type
    • 10.6.5. Market Size Analysis, and Y-o-Y Growth Analysis (%), By End user

11. Competitive Landscape

  • 11.1. Key Developments and Strategies
  • 11.2. Company Share Analysis
  • 11.3. Product Benchmarking
  • 11.4. List of Key Companies to Watch

12. Company Profiles

  • 12.1. HORIBA Medical*
    • 12.1.1. Company Overview
    • 12.1.2. Product Portfolio and Description
    • 12.1.3. Key Highlights
    • 12.1.4. Financial Overview
  • 12.2. LINEAR CHEMICALS S.L.U.
  • 12.3. BioSystems S.A.
  • 12.4. Rayto Life and Analytical Sciences Co.,Ltd.
  • 12.5. Micro Lab Instruments
  • 12.6. TECO Medical Instruments
  • 12.7. Helena Biosciences
  • 12.8. Genrui Biotech Inc.
  • 12.9. Biobase
  • 12.10. Maccura Biotechnology Co., Ltd.

LIST NOT EXHAUSTIVE

13. Global Channel Coagulometer Market - DataM

  • 13.1. Appendix
  • 13.2. About Us and Applications
  • 13.3. Contact Us